信铭生命科技年报 2022/23

Contents 目录 2 CorporateInformation公司资料 75 ConsolidatedStatementofFinancialPosition综合财务状况报表 4 Director’sStatement董事报告书 78 ConsolidatedStatementofChangesinEquity综合权益变动表 5 ManagementDiscussionandAnalysis管理层讨论及分析 80 ConsolidatedStatementofCashFlows综合现金流量表 29 BiographicalDetailsofDirectorsandSeniorManagement董事及高级管理层履历详情 83 NotestotheConsolidatedFinancialStatements综合财务报表附注 32 CorporateGovernanceReport企业管治报告 200 FinancialSummary财务概要 52 ReportofDirectors董事会报告 66 IndependentAuditor’sReport独立核数师报告 73 ConsolidatedStatementofProfitorLossandOtherComprehensiveIncome综合损益及其他全面收益表 CORPORATEINFORMATION 公司资料 EXECUTIVEDIRECTORS Mr.XuHaiying Dr.ZhiliangOu,J.P.(Australia) Mr.FokChiTak INDEPENDENTNON-EXECUTIVEDIRECTORS Mr.ChanMingSunJonathanMr.LamKwanSing Mr.MakYiuTong AUDITCOMMITTEE Mr.ChanMingSunJonathan(ChairmanofCommittee) Mr.LamKwanSingMr.MakYiuTong EXECUTIVECOMMITTEE Mr.XuHaiying Dr.ZhiliangOu,J.P.(Australia) Mr.FokChiTak REMUNERATIONCOMMITTEE Mr.ChanMingSunJonathan(ChairmanofCommittee) Dr.ZhiliangOu,J.P.(Australia) Mr.LamKwanSing NOMINATIONCOMMITTEE Mr.MakYiuTong(ChairmanofCommittee) Dr.ZhiliangOu,J.P.(Australia)Mr.ChanMingSunJonathanMr.LamKwanSing AUTHORIZEDREPRESENTATIVES Mr.FokChiTak Dr.ZhiliangOu,J.P.(Australia) COMPANYSECRETARY Mr.SiuChunPongRaymond(appointedon26August2022) Ms.ChanLaiPing (resignedon26August2022) 执行董事 许海鹰先生 欧志亮博士，太平绅士（澳洲）霍志德先生 独立非执行董事 陈铭燊先生林君诚先生麦耀棠先生 审核委员会 陈铭燊先生（委员会主席）林君诚先生 麦耀棠先生 执行委员会 许海鹰先生 欧志亮博士，太平绅士（澳洲）霍志德先生 薪酬委员会 陈铭燊先生（委员会主席）欧志亮博士，太平绅士（澳洲）林君诚先生 提名委员会 麦耀棠先生（委员会主席）欧志亮博士，太平绅士（澳洲）陈铭燊先生 林君诚先生 授权代表 霍志德先生 欧志亮博士，太平绅士（澳洲） 公司秘书 萧镇邦先生 （于二零二二年八月二十六日获委任）陈丽平女仕 （于二零二二年八月二十六日获委任） 2AcesoLifeScienceGroupLimitedAnnualReport2022/23 CORPORATEINFORMATION 公司资料 LEGALADVISER RaymondSiu&Lawyers AUDITOR ZHONGHUIANDACPALimited CertifiedPublicAccountants PRINCIPALBANKERS ShanghaiCommercialBankLimited TheHongkongandShanghaiBankingCorporationLimitedNanyangCommercialBank,Ltd. BankofChina(HongKong)LimitedTheBankofEastAsiaLimited PRINCIPALSHAREREGISTRARANDTRANSFEROFFICEINCAYMANISLANDS Suntera(Cayman)Limited Suite3204,Unit2A,Block3,BuildingD P.O.Box1586,GardeniaCourtCamanaBay GrandCayman,KY1–1100CaymanIslands BRANCHSHAREREGISTRARANDTRANSFEROFFICEINHONGKONG ComputershareHongKongInvestorServicesLimitedShops1712–1716 17thFloor,HopewellCentre 183Queen’sRoadEast,WanChaiHongKong REGISTEREDOFFICE CricketSquareHutchinsDrive P.O.Box2681 GrandCaymanKY1–1111CaymanIslands PRINCIPALPLACEOFBUSINESSINHONGKONG Rooms2501–2509,25/F ShuiOnCentre 6–8HarbourRoad,WanchaiHongKong WEBSITE www.acesogrouphk.com 法律顾问 萧镇邦律师行 核数师 中汇安达会计师事务所有限公司执业会计师 主要往来银行 上海商业银行有限公司 香港上海汇丰银行有限公司南洋商业银行有限公司 中国银行（香港）有限公司东亚银行有限公司 开曼群岛主要股份过户登记处 Suntera(Cayman)Limited Suite3204,Unit2A,Block3,BuildingD P.O.Box1586,GardeniaCourtCamanaBay GrandCayman,KY1-1100CaymanIslands 香港股份过户登记分处 香港中央证券登记有限公司香港 湾仔皇后大道东183号合和中心17楼 1712-1716号铺 注册办事处 CricketSquareHutchinsDrive P.O.Box2681 GrandCaymanKY1-1111CaymanIslands 香港主要营业地点 香港 湾仔港湾道6-8号瑞安中心 25楼2501-2509室 网址 www.acesogrouphk.com 二零二二年/二三年年报信铭生命科技集团有限公司3 DIRECTOR’SSTATEMENT 董事报告书 Theboard(the“Board”)ofdirectors(the“Directors”)ofAcesoLifeScienceGroupLimited(the“Company”)ispleasedtopresenttheshareholdersoftheCompany(the“Shareholders”)theannualresultsoftheCompanyanditssubsidiaries(the“Group”)fortheyearended31March2023(the“Year”). Afterthreeyears,theworldhasfinallyrecoveredfromthepandemicandmovedtowardsthe“post-pandemicera”.However,theglobaleconomystillfacedmanychallenges,includingtheongoingRussian-Ukrainewar,geopoliticaltensions,highglobalinflationandinterestrate,whichalsohadacertainimpactonglobaleconomicactivities.Amongthiscomplicatedexternalenvironment,theGrouphasadoptedasoundfinancialpolicy,andactivelyexplorednewdevelopmentopportunities. WeexpectedtheYear2023marketconditionstobesimilartolastyear.Althoughtheglobalandlocaleconomicandbusinessenvironmentisstillaffectedbytheuncertainties,theGroupwillcontinuetocreatevalueforshareholdersandseizeopportunities,continuetooptimizeitsbusinessportfolio,andgetreadyfornewinvestmentopportunities. Intermsoftheexistingconstructionmachinerybusiness,duetotherelativelystableundertakingofgovernmentinfrastructureprojects,theGroupmanagedtorecordanincreaseinthe(i)salesofconstructionmachineryandspareparts,and (ii)rentalincomegeneratedfromconstructionmachineryduringtheYear.Theoccupancyratefortherentalmachinerieswasapproximately90%. Forthefinancialservicesbusiness,weshallcontinueourbusinessexpansionwithacautiousandpositiveattitude.TheGroupisconfidentintheprospectsofthefinancialmarketsinHongKongandtheMainlandChina,andwouldliketoincreaseitspresenceinthefinancialmarketsbyeitherorganicgrowthorworkingwithreputablepartners. ForourinvestmentpropertyintheUnitedKingdom(the“UK”),55MarkLane,therentalincomeissteadythroughtheYear.TheGroupdoesnotforeseesignificantfluctuationinrentalincomeinYear2023. Finally,onbehalfoftheBoard,IwouldliketoexpressmysinceregratitudetoalltheShareholdersfortheirfullsupport,andappreciatethedirectors,themanagementandthestafffortheirvaluablecontributionstotheGroup,whichshallstrivetostreamlineitsexistingbusin